Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 364.00
Bid: 364.00
Ask: 373.00
Change: -11.00 (-2.93%)
Spread: 9.00 (2.473%)
Open: 354.00
High: 364.00
Low: 354.00
Prev. Close: 375.00
WIL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Financial Research Associates LLC

7 Jul 2015 07:00

RNS Number : 3150S
Wilmington PLC
07 July 2015
 

 

7 July 2015

Wilmington plc

 

Acquisition of Financial Research Associates LLC

 

- Enhances networking capability of Finance and Insight knowledge centres -

- Strengthens Wilmington's presence in North America -

 

Wilmington plc ("Wilmington" or "the Group"), the knowledge leader in Risk & Compliance, Finance, Legal, and Insight, announces the acquisition of the trading assets and assumption of certain liabilities of Financial Research Associates LLC ("FRA" or "the business"), a leading US conference and networking provider of specialist events in healthcare and finance, for a maximum consideration of up to $20.6m (£13.2m).

 

Terms of the deal

 

Wilmington is acquiring FRA from its founding management team, who will continue in the business. The acquisition comprises a net initial consideration of $13.0m (£8.3m) in cash with two deferred cash consideration amounts of $1.5m each payable on 1 July 2016 and 1 July 2017 conditional upon the continued employment of the management team. Further deferred consideration of up to $4.6m is potentially payable in cash subject to FRA achieving challenging revenue and profit targets in the two financial years ended 30 June 2016 and June 2017 respectively.

 

The net initial consideration and any deferred consideration will be financed out of the Group's existing £65m multicurrency debt facility. The acquisition is expected to be earnings enhancing in the first full year of ownership. As previously announced on 2 July 2015, Wilmington has extended its £65m revolving credit until 1 July 2020 with an option to increase the facility to a total commitment of £100m.

 

Background to FRA

 

FRA, was established in 2001 and is managed by Lori Medlen, CEO and Ellen Wofford, COO. The business has a successful portfolio of over 80 specialist events, focussed on finance and healthcare. FRA has 47 employees based in two offices; Charlotte, North Carolina and Santa Cruz, California. It enjoys a high proportion of repeatable revenue with over 75 percent of 2014 revenue coming from recurring annual events. Approximately 60 percent of revenue comes from healthcare events (healthcare forms the majority of Wilmington's Insight division) and 40 percent from Finance. In line with Wilmington's ambition to enhance its international presence, FRA's turnover is generated in the US and its acquisition will increase the proportion of the Group's revenue generated from international markets.

 

In the twelve month period ending 31 December 2014, revenue for FRA was $10.5m and underlying revenue increased by 19 percent driven by the success of its two flagship healthcare events; Resource Initiative and Society for Education ("RISE") held annually in Nashville and California. The RISE events are the premier events for healthcare professionals and executives from all industry segments as well as healthcare providers and have a membership association of over 1,000 members.

During the twelve month period ending 31 December 2014, FRA made an adjusted profit before interest, amortisation and taxation of $2.6m1 and had gross assets of $1.4m1. At 30 June 2015 the value of assets and of certain liabilities acquired resulted in a net liability of $0.4m1.

 

Acquisition rationale

 

The acquisition of FRA is consistent with Wilmington's strategy of acquiring complimentary businesses with high repeat revenues and strong, cash generative income streams in the Group's key markets. FRA's business provides Wilmington with additional networking expertise and will support the Wilmington Insight and Finance divisions.

 

FRA will work closely with other Wilmington companies in the US, including Compliance Week (the provider of governance, risk and compliance information), and with UK companies seeking US market access in particular NHiS (the provider of business intelligence and data analysis to the pharmaceutical industry), which will benefit from FRA's extensive database contact list of more than 300,000 healthcare contacts. FRA will also work with AMT (the provider of corporate finance and capital markets training to major international investment banks). FRA has 900,000 finance contacts in its database built up over 15 years.

 

FRA's established relationships will provide Wilmington's international businesses with networking opportunities, enabling closer access to a wider pool of North American customers and markets. In turn, Wilmington sees opportunities to "geo-clone" FRA events internationally and is already investigating opportunities in the UK and Europe.

 

1 unaudited before non-recurring costs which are not being acquired of $2.2m.

 

No new financial information will be presented at the Capital Markets day event for shareholders and analysts being held this morning at 9.30 a.m.

 

 

 

Commenting on the acquisition, Pedro Ros, Chief Executive Officer of Wilmington, said:

 

"FRA is a quality business with excellent market positions supported by an entrepreneurial and ambitious management team. This earnings enhancing acquisition provides Wilmington with new networking opportunities and capabilities within our Finance and Healthcare areas.

 

We are delighted that Lori, Ellen and the rest of the FRA team are joining Wilmington at this exciting time in our evolution. The acquisition will also strengthen our base in North America as we look to further internationalise our business."

 

Lori Medlen CEO of FRA commented: 

 

"We are thrilled to be joining Wilmington and look forward to providing live event networking opportunities to support the Insight and Finance divisions. We are delighted to be part of a larger organisation which can develop our growth ambitions."

 

For further information, please contact:

Wilmington plc

Pedro Ross, Chief Executive Officer

Tony Foye, Chief Financial Officer

020 7422 6800

FTI Consulting

Charles Palmer

Emma Appleton

020 3727 1000

 

Notes to Editors

 

Wilmington plc is the recognised knowledge leader and partner of choice for information, education and networking in Risk & Compliance, Finance and Legal as well as the Insight leader in a number of chosen industries. Capitalised at approximately £220 million, Wilmington floated on the London Stock Exchange in 1995.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQPKADNKBKBOOK
Date   Source Headline
26th Apr 20247:46 amRNSAPM sold for EUR 26 million
23rd Apr 20243:49 pmRNSSAYE and Director/PDMR Shareholding
19th Feb 20247:00 amRNSHalf-year Report
6th Feb 202411:12 amRNSBoard Changes
1st Feb 20247:00 amRNSMiExact sold for £9.6 million
18th Jan 202411:00 amRNSNotice of Half Year Results
2nd Jan 20247:00 amRNSTotal Voting Rights
18th Dec 20232:42 pmRNSIssue of ordinary shares
11th Dec 20233:54 pmRNSIssue of Ordinary Shares
7th Dec 20232:25 pmRNSIssue of Ordinary Shares
1st Dec 202311:40 amRNSDirector/PDMR Shareholding
30th Nov 20232:53 pmRNSIssue of Ordinary Shares
23rd Nov 20239:49 amRNSAcquisition of Astutis Ltd by Wilmington plc
22nd Nov 20232:37 pmRNSResult of AGM
1st Nov 20237:00 amRNSTotal Voting Rights
3rd Oct 20232:52 pmRNSHolding(s) in Company
2nd Oct 202311:57 amRNSDirector/PDMR Shareholding
2nd Oct 202310:19 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSIssue of Ordinary Shares
25th Sep 20236:06 pmRNSAmendment to Financial Results announcement
25th Sep 20237:00 amRNSFinancial results for the year ended 30 June 2023
26th Jul 20237:00 amRNSTrading Statement
11th Apr 20237:00 amRNSSAYE and Director/PDMR Shareholding
7th Mar 20235:32 pmRNSHolding(s) in Company
20th Feb 20237:00 amRNSHalf-year Report
9th Feb 202312:36 pmRNSHolding(s) in Company
1st Feb 20237:00 amRNSTotal Voting Rights
24th Jan 202310:30 amRNSNotice of Half Year-End Results
19th Dec 202211:32 amRNSHolding(s) in Company
12th Dec 20227:00 amRNSJoint Broker appointment
5th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Dec 20222:50 pmRNSHolding(s) in Company
1st Dec 20227:00 amRNSTotal Voting Rights
23rd Nov 20223:12 pmRNSResult of AGM
15th Nov 20222:31 pmRNSHolding(s) in Company
17th Oct 202212:11 pmRNSHoling(s) in Company
17th Oct 202212:11 pmRNSHolding(s) in Company
3rd Oct 20225:52 pmRNSDirector/PDMR Shareholding
3rd Oct 20225:51 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSTotal Voting Rights
30th Sep 20224:42 pmRNSSecond Price Monitoring Extn
30th Sep 20224:36 pmRNSPrice Monitoring Extension
29th Sep 20223:43 pmRNSHolding(s) in Company
29th Sep 20223:36 pmRNSIssue of ordinary shares
22nd Sep 20227:00 amRNSFinancial results for the year ended 30 June 2022
31st Aug 20227:00 amRNSNotice of Results
19th Aug 20225:07 pmRNSDirector/PDMR Shareholding
1st Aug 20227:00 amRNSTotal Voting Rights
27th Jul 20227:00 amRNSYear-End Trading Update
1st Jul 20227:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.